9 results on '"Kinnerup M"'
Search Results
2. Noradrenergic mechanisms in Parkinson’s disease, studied with [18F]FDOPA and [11C]MeNER PET
- Author
-
Kinnerup, M., Sommerauer, M., Østergaard, K., Borghammer, P., Gjedde, A., Nahimi, A., Kinnerup, M., Sommerauer, M., Østergaard, K., Borghammer, P., Gjedde, A., and Nahimi, A.
- Published
- 2017
3. In-vivo imaging of a2 adrenoceptors in Parkinson's disease with 11C-yohimbine
- Author
-
Nahimi, A., Kinnerup, M. B., Ostergaard, K., Winterdahl, M., Fedorova, T., Jakobsen, S., Schaldemose, J., Sommerauer, M., Borghammer, P., Gjedde, A., Nahimi, A., Kinnerup, M. B., Ostergaard, K., Winterdahl, M., Fedorova, T., Jakobsen, S., Schaldemose, J., Sommerauer, M., Borghammer, P., and Gjedde, A.
- Published
- 2017
4. Noradrenergic deficits in Parkinson's disease:Relations to cognitive and cortical oscillatory activity declines
- Author
-
Nahimi, A., Sommerauer, M., Ostergaard, K., Kinnerup, M. B., Winterdahl, M., Krogbaek, R., Jacobsen, J., Schacht, A., Borghammer, P., Damholdt, M. F., Johnsen, B., Gjedde, A., Nahimi, A., Sommerauer, M., Ostergaard, K., Kinnerup, M. B., Winterdahl, M., Krogbaek, R., Jacobsen, J., Schacht, A., Borghammer, P., Damholdt, M. F., Johnsen, B., and Gjedde, A.
- Abstract
Objectives: In vitro studies suggest that noradrenergic projections from locus coeruleus to subcortical and cortical brain structures, e.g., thalamus, undergo severe neurodegeneration in Parkinson’s disease (PD). Loss of noradrenergic projections may alter oscillatory activity that in turn may be associated with cognitive decline. To test this hypothesis of the origin of cognitive decline in this disease, we used positron emission tomography (PET) to quantify the density of noradrenergic projections in groups of PD patients and healthy controls (HC), in combination with neuropsychological assessment and recording of quantitative electroencephalography (qEEG). Methods: Following administration of 11C-MeNER, the positron-emitting form of a selective noradrenaline reuptake transporter antagonist, 17 non-demented PD patients and 10 HC underwent 90–120 minutes' dynamic PET. The caudate was established as the reference region in datasets with arterial blood samples. The binding potential of 11C-MeNER relative to non-displaceable tracer (BPND) was estimated with the simplified reference tissue model 2 (SRTM2), correlated to cognitive function in four domains, and to changes of cortical oscillatory activities measured with qEEG. Results: Global 11C-MeNER BPND values were reduced numerically in the PD group, with regionally significant declines in the thalamus, hypothalamus, and nucleus ruber. Tremor was associated with attenuated decline of tracer binding. The value of thalamic 11C-MeNER BPND was associated with cognitive performance, independent of premorbid cognitive function or disease. PD patients had significant slowing of qEEG, e.g., the background alpha rhythm, but only EEG reactivity upon eye opening correlated with thalamic 11C-MeNER BPND in PD patients. Conclusion: This is the first direct quantification of noradrenergic denervation in vivo in PD patients. In agreement with predictions from in vitro studies, we discovered a global declin
- Published
- 2017
5. Use, failure, and non-compliance of respiratory personal protective equipment and risk of upper respiratory tract infections-A longitudinal repeated measurement study during the COVID-19 pandemic among healthcare workers in Denmark.
- Author
-
Biering K, Kinnerup M, Cramer C, Dalbøge A, Toft Würtz E, Lund Würtz AM, Kolstad HA, Schlünssen V, Meulengracht Flachs E, and Nielsen KJ
- Subjects
- Humans, Denmark epidemiology, Longitudinal Studies, Male, Female, Adult, Middle Aged, Respiratory Protective Devices statistics & numerical data, Respiratory Protective Devices standards, Guideline Adherence statistics & numerical data, Pandemics, COVID-19 prevention & control, COVID-19 epidemiology, Health Personnel statistics & numerical data, Respiratory Tract Infections epidemiology, SARS-CoV-2
- Abstract
Introduction: Upper respiratory tract infections (URTI) are common and a common cause of sick-leave for healthcare workers, and furthermore pose a threat especially for patients susceptible to other diseases. Sufficient use of respiratory protective equipment (RPE) may protect both the workers and the patients. The COVID-19 pandemic provided a unique opportunity to study the association between use of RPE and URTI in a real-life setting. The aim of this study was to examine if failure of RPE or non-compliance with RPE guidelines increases the risk of non-COVID-19 URTI symptoms among healthcare workers., Methods: In a longitudinal cohort study, we collected self-reported data daily on work tasks, use of RPE, and URTI symptoms among healthcare workers with patient contact in 2 Danish Regions in 2 time periods during the COVID-19 pandemic. The association between failure of RPE or non-compliance with RPE guidelines and URTI symptoms was analyzed separately by generalized linear models. Persons tested positive for severe acute respiratory syndrome coronavirus 2 were censored from the analyses. The 2 waves of data collection were analyzed separately, as there were differences in recommendations of RPE during the 2 waves., Results: We found that for healthcare workers performing work tasks with a risk of transmission of viruses or bacteria, failure of RPE was associated with an increased risk of URTI symptoms, RR: 1.65[0.53-5.14] in wave 1 and RR: 1.30[0.56-3.03] in wave 2. Also non-compliance with RPE guidelines was associated with an increased risk of URTI symptoms compared to the use of RPE in wave 1, RR: 1.28[0.87-1.87] and wave 2, RR: 1.39[1.01-1.91]. Stratifying on high- versus low-risk tasks showed that the risk related to failure and non-compliance was primarily associated with high-risk tasks, although not statistically significant., Discussion: The study was conducted during the COVID-19 pandemic and thus may be affected by other preventive measures in society. However, this gave the opportunity to study the use of RPE in a real-life setting, also in departments that did not previously use RPE. The circumstances in the 2 time periods of data collection differed and were analyzed separately and thus the sample size was limited and affected the precision of the estimates., Conclusion: Failures of RPE and non-compliance with RPE guidelines may increase the risk of URTI, compared to those who reported use of RPE as recommended. The implications of these findings are that the use of RPE to prevent URTI could be considered, especially while performing high-risk tasks where other prevention strategies are not achievable., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.)
- Published
- 2024
- Full Text
- View/download PDF
6. EEG Frequency Correlates with α 2 -Receptor Density in Parkinson's Disease.
- Author
-
Kemp AF, Kinnerup M, Johnsen B, Jakobsen S, Nahimi A, and Gjedde A
- Subjects
- Humans, Electroencephalography methods, Norepinephrine, Receptors, Adrenergic, Parkinson Disease, Cognitive Dysfunction
- Abstract
Introduction: Increased theta and delta power and decreased alpha and beta power, measured with quantitative electroencephalography (EEG), have been demonstrated to have utility for predicting the development of dementia in patients with Parkinson's disease (PD). Noradrenaline modulates cortical activity and optimizes cognitive processes. We claim that the loss of noradrenaline may explain cognitive impairment and the pathological slowing of EEG waves. Here, we test the relationship between the number of noradrenergic α
2 adrenoceptors and changes in the spectral EEG ratio in patients with PD., Methods: We included nineteen patients with PD and thirteen healthy control (HC) subjects in the study. We used positron emission tomography (PET) with [11 C]yohimbine to quantify α2 adrenoceptor density. We used EEG power in the delta (δ, 1.5-3.9 Hz), theta (θ, 4-7.9 Hz), alpha (α, 8-12.9 Hz) and beta (β, 13-30 Hz) bands in regression analyses to test the relationships between α2 adrenoceptor density and EEG band power., Results: PD patients had higher power in the theta and delta bands compared to the HC volunteers. Patients' theta band power was inversely correlated with α2 adrenoceptor density in the frontal cortex. In the HC subjects, age was correlated with, and occipital background rhythm frequency (BRF) was inversely correlated with, α2 adrenoceptor density in the frontal cortex, while occipital BRF was inversely correlated with α2 adrenoceptor density in the thalamus., Conclusions: The findings support the claim that the loss or dysfunction of noradrenergic neurotransmission may relate to the parallel processes of cognitive decline and EEG slowing., Competing Interests: The authors declare no conflicts of interest.- Published
- 2024
- Full Text
- View/download PDF
7. Intestinal Transit in Early Moderate Parkinson's Disease Correlates with Probable RBD: Subclinical Esophageal Dysmotility Does Not Correlate.
- Author
-
Skjærbæk C, Knudsen K, Kinnerup M, Hansen KV, and Borghammer P
- Abstract
Background: Nonmotor symptoms, including constipation and dysphagia, are very common in Parkinson's disease (PD) and Lewy pathology is widespread in the gastrointestinal tract, particularly in the lower esophagus. Constipation and REM sleep behavior disorder (RBD) may present prior to clinical diagnosis. Yet, little is known about esophageal dysfunction and its connection to constipation in early PD., Objective: This study aimed to investigate esophageal and colonic transit in early moderate PD and to study correlations between symptoms and objective measures., Methods: Thirty early moderate PD patients and 28 healthy controls (HC) were included in this cross-sectional study. Esophageal transit times were determined by esophageal scintigraphy and colonic transit times by CT after radio-opaque marker ingestion. Olfaction tests, clinical evaluation, and nonmotor questionnaires were also performed., Results: Distal esophageal transit times and colonic transit times were both significantly prolonged in the PD group compared to HC ( p < 0.05 and p < 0.01, respectively) and a moderate-strong positive correlation was found between colonic transit time (CTT) and RBDSQ score ( r = 0.61, p < 0.001). Significant correlations were also found between CTT and SCOPA-AUT scores as well as between CTT and ROME III functional constipation scores., Conclusion: Colonic transit correlates with probable RBD and is more severely prolonged in early moderate PD than is the distal esophageal transit time., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2022 Casper Skjærbæk et al.)
- Published
- 2022
- Full Text
- View/download PDF
8. Disruption of Sleep Microarchitecture Is a Sensitive and Early Marker of Parkinson's Disease.
- Author
-
Doppler CEJ, Smit J, Hommelsen M, Seger A, Okkels N, Horsager J, Kinnerup M, Hansen AK, Fedorova TD, Knudsen K, Otto M, Nahimi A, Fink GR, Borghammer P, and Sommerauer M
- Subjects
- Humans, Sleep, Polysomnography, Parkinson Disease complications, Parkinson Disease diagnosis, REM Sleep Behavior Disorder
- Abstract
Background: Although sleep disturbances are highly prevalent in patients with Parkinson's disease, sleep macroarchitecture metrics show only minor changes., Objective: To assess alterations of the cyclic alternating pattern (CAP) as a critical feature of sleep microarchitecture in patients with prodromal, recent, and established Parkinson's disease., Methods: We evaluated overnight polysomnography for classic sleep macroarchitecture and CAP metrics in 68 patients at various disease stages and compared results to 22 age- and sex-matched controls., Results: Already at the prodromal stage, patients showed a significantly reduced CAP rate as a central characteristic of sleep microarchitecture. Temporal characteristics of CAP showed a gradual change over disease stages and correlated with motor performance. In contrast, the sleep macroarchitecture metrics did not differ between groups., Conclusion: Data suggest that alterations of sleep microarchitecture are an early and more sensitive characteristic of Parkinson's disease than changes in sleep macroarchitecture.
- Published
- 2022
- Full Text
- View/download PDF
9. Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder - A PET study.
- Author
-
Andersen KB, Hansen AK, Sommerauer M, Fedorova TD, Knudsen K, Vang K, Van Den Berge N, Kinnerup M, Nahimi A, Pavese N, Brooks DJ, and Borghammer P
- Subjects
- Aged, Dihydroxyphenylalanine analogs & derivatives, Female, Humans, Male, Middle Aged, Morpholines, Parkinson Disease complications, Parkinson Disease diagnostic imaging, Positron-Emission Tomography, Putamen diagnostic imaging, REM Sleep Behavior Disorder diagnostic imaging, REM Sleep Behavior Disorder etiology, Sensorimotor Cortex diagnostic imaging, Thalamus diagnostic imaging, Norepinephrine metabolism, Parkinson Disease metabolism, Putamen metabolism, REM Sleep Behavior Disorder metabolism, Sensorimotor Cortex metabolism, Thalamus metabolism
- Abstract
Introduction: Noradrenergic denervation is thought to aggravate motor dysfunction in Parkinson's disease (PD). In a previous PET study with the norepinephrine transporter (NART) ligand
11 C-MeNER, we detected reduced NART binding in primary sensorimotor cortex (M1S1) of PD patients. Idiopathic rapid-eye-movement sleep behaviour disorder (iRBD) is a phenotype of prodromal PD. Using11 C-MeNER PET, we investigated whether iRBD patients showed similar NART binding reductions in M1S1 cortex as PD patients. Additionally, we investigated whether11 C-MeNER binding and loss of nigrostriatal dopamine storage capacity measured with18 F-DOPA PET were correlated., Methods: 17 iRBD patients, 16 PD patients with (PDRBD+ ) and 14 without RBD (PDRBD- ), and 25 control subjects underwent11 C-MeNER PET. iRBD patients also had18 F-DOPA PET. Volume-of-interest analyses and voxel-level statistical parametric mapping were performed., Results: Partial-volume corrected11 C-MeNER binding potential (BPND ) values in M1S1 differed across the groups (P = 0.022) with the iRBD and PDRBD+ groups showing significant reductions (controls vs. iRBD P = 0.007; control vs. PDRBD+ P = 0.008). Voxel-wise comparisons confirmed reductions of M1S111 C-MeNER binding in PD and iRBD patients. Significant correlation was seen between putaminal18 F-DOPA uptake and thalamic11 C-MeNER binding in iRBD patients (r2 = 0.343, P = 0.013)., Conclusions: This study found altered noradrenergic neurotransmission in the M1S1 cortex of iRBD patients. The observed reduction of M1S111 C-MeNER binding in iRBD may represent noradrenergic terminal degeneration or physiological down-regulation of NARTs in this prodromal phenotype of PD. The correlation between thalamic11 C-MeNER binding and putaminal18 F-DOPA binding suggests that these neurotransmitter systems degenerate in parallel in the iRBD phenotype of prodromal PD., (Copyright © 2020 Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.